A carregar...
Utilization and factors precluding the initiation of consolidative durvalumab in unresectable stage III non-small cell lung cancer
Durvalumab after concurrent chemoradiation has significantly improved survival in stage III non-small cell lung cancer (NSCLC). However, there is limited data evaluating the utilization and challenges to deliver durvalumab consolidation in the real world. We assessed the use of consolidative durvalu...
Na minha lista:
| Publicado no: | Radiother Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7523024/ https://ncbi.nlm.nih.gov/pubmed/31786421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2019.11.015 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|